CAM
MET icon

Cresset Asset Management’s MetLife MET Stock Holding History

Cresset Asset Management’s Portfolio MET Stock Details MET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.3M Sell
18,382
-264
-1% -$19.8K 0.01% 694
2025
Q4 		$1.47M Sell
18,646
-566
-3% -$44.8K 0.01% 655
2025
Q3 		$1.58M Buy
19,212
+403
+2% +$31.7K 0.01% 615
2025
Q2 		$1.51M Sell
18,809
-3,006
-14% -$232K 0.01% 569
2025
Q1 		$1.75M Buy
21,815
+892
+4% +$74.2K 0.01% 577
2024
Q4 		$1.71M Sell
20,923
-30,869
-60% -$2.57M 0.01% 602
2024
Q3 		$4.27M Buy
51,792
+2,824
+6% +$211K 0.02% 487
2024
Q2 		$3.44M Buy
48,968
+8,541
+21% +$610K 0.01% 524
2024
Q1 		$3M Sell
40,427
-506
-1% -$35.3K 0.01% 490
2023
Q4 		$2.71M Buy
40,933
+6,476
+19% +$405K 0.02% 466
2023
Q3 		$2.17M Sell
34,457
-568
-2% -$35.4K 0.01% 527
2023
Q2 		$1.98M Buy
35,025
+21,443
+158% +$1.19M ﹤0.01% 653
2023
Q1 		$787K Buy
13,582
+736
+6% +$49.7K 0.02% 387
2022
Q4 		$857K Sell
12,846
-1,434
-10% -$103K 0.01% 328
2022
Q3 		$867K Sell
14,280
-835
-6% -$53.3K 0.01% 386
2022
Q2 		$949K Sell
15,115
-748
-5% -$49.5K 0.01% 392
2022
Q1 		$1.12M Sell
15,863
-3,033
-16% -$205K 0.01% 380
2021
Q4 		$1.18M Buy
18,896
+160
+0.9% +$10K 0.01% 404
2021
Q3 		$1.16M Buy
18,736
+2,489
+15% +$150K 0.02% 349
2021
Q2 		$973K Sell
16,247
-2,479
-13% -$157K 0.01% 362
2021
Q1 		$1.14M Buy
18,726
+1,531
+9% +$84.5K 0.02% 263
2020
Q4 		$807K Sell
17,195
-1,398
-8% -$60.6K 0.01% 284
2020
Q3 		$692K Sell
18,593
-263
-1% -$9.98K 0.01% 305
2020
Q2 		$689K Buy
18,856
+9,292
+97% +$323K 0.02% 273
2020
Q1 		$292K Buy
9,564
+1,359
+17% +$60.3K 0.01% 399
2019
Q4 		$418K Buy
8,205
+488
+6% +$23.6K 0.01% 334
2019
Q3 		$364K Buy
7,717
+3,242
+72% +$155K 0.01% 328
2019
Q2 		$222K Buy
4,475
+705
+19% +$33.1K 0.01% 415
2019
Q1 		$160K Buy
3,770
+624
+20% +$27.6K 0.01% 427
2018
Q4 		$129K Buy
+3,146
New +$135K 0.01% 279

Other funds holding MET

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Cresset Asset Management's MET Position: Q1 2026 in Review

Cresset Asset Management reduced its MetLife (MET) stake by 1.4% in Q1 2026, selling an estimated $19.8K and leaving 18,382 shares worth $1.3M. The position accounts for 0.01% of the portfolio, ranked #694.

Cresset Asset Management first reported a position in MET in Q4 2018 and has held it in 30 quarters since. The position peaked at $4.27M in Q3 2024. 1,372 funds tracked by Wall St. Rank hold MET as of Q1 2026.

  • Cresset Asset Management held 18,382 shares of MetLife worth $1.3M as of Q1 2026.
  • Cresset Asset Management sold 264 MetLife shares in Q1 2026, an estimated $19.8K.
  • MetLife made up 0.01% of Cresset Asset Management's portfolio in Q1 2026, its #694 holding.
  • Cresset Asset Management first reported a position in MetLife in Q4 2018 and has held it in 30 quarters since.
  • Cresset Asset Management's MetLife position peaked at $4.27M in Q3 2024.
  • 1,372 funds tracked by Wall St. Rank held MetLife as of Q1 2026.

Based on Cresset Asset Management's 13F filing for Q1 2026, filed 15 May 2026.